1. DSpace at Riga Stradiņš University

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-7 of 7 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Jan-2012Pathological Complete Remission in Young Colon Cancer Patient with a Large Liver Metastasis after FOLFOX-4/Bevacizumab Treatment – A Case ReportSkuja, Elīna; Āboliņš, Arnis; Priedīte, Ilze; Purkalne, Gunta; Štrumfa, Ilze; Vilmanis, Jānis; Kalniete, Dagnija; Miklaševičs, Edvīns; Gardovskis, Jānis; RSU Institute of Oncology
1-Dec-2013Neoadjuvant Chemoradiation in Patient with Localy Advanced Rectal CancerSkuja, Elina; Sorubalko, Arturs; Purkalne, Gunta; Miklasevics, Edvins; RSU Institute of Oncology
27-Apr-2018Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer : A retrospective cohort analysis and literature reviewSæther, Nikolai Havn; Skuja, Elina; Irmejs, Arvids; Maksimenko, Jelena; Miklasevics, Edvins; Purkalne, Gunta; Gardovskis, Janis; Rīga Stradiņš University
Feb-2017Chromothripsis and progression-free survival in metastatic colorectal cancerSkuja, Elina; Kalniete, Dagnija; Nakazawa-Miklaševiča, Miki; Daneberga, Zanda; Abolins, Arnis; Purkalne, Gunta; Miklasevics, Edvins; RSU Institute of Oncology
27-Oct-2011Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from LatviaPlakhins, Grigorijs; Irmejs, Arvids; Gardovskis, Andris; Subatniece, Signe; Rozite, Santa; Bitina, Marianna; Keire, Guntars; Purkalne, Gunta; Teibe, Uldis; Trofimovics, Genadijs; Miklasevics, Edvins; Gardovskis, Janis; Hereditary Cancer Research Department
2019Role of percutaneous needle biopsy of axillary lymph nodes to evaluate node positive breast cancer after neoadjuvant chemotherapyLīcīte, Baiba; Irmejs, Arvīds; Maksimenko, Jeļena; Loža, Pēteris; Trofimovičs, Genadijs; Miklaševičs, Edvīns; Nazarovs, Jurijs; Romanovska, M.; Deičmane, J.; Purkalne, Gunta; Gardovskis, Jānis; Department of Surgery; RSU Institute of Oncology
25-May-2018Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC) : An open-label, non-randomized, multicenter, phase IV clinical trialMarkóczy, Zsolt; Sárosi, Veronika; Kudaba, Iveta; Gálffy, Gabriella; Turay, Ülkü Yilmaz; Demirkazik, Ahmet; Purkalne, Gunta; Somfay, Attila; Pápai-Székely, Zsolt; Rásó, Erzsébet; Ostoros, Gyula; RSU Institute of Oncology

Discover